Cartesian Therapeutics, Inc. (RNAC) has 26 open-market insider trades by 8 insiders since 2024. The most active filer is Timothy A. Springer, Director & 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Timothy A. Springer | Dir10% Owner | — | 10 | $31.3M | 2026-01-02 |
| Metin Kurtoglu | CTO | — | 4 | $4.8M | 2025-01-06 |
| Christopher M. Jewell | CSO | — | 2 | $1.2M | 2025-01-10 |
| Milos Miljkovic | — | — | 3 | $963K | 2026-01-06 |
| Carsten Brunn | CEOPres | — | 2 | $742K | 2026-01-06 |
| Blaine Davis | CFO | — | 2 | $340K | 2026-01-06 |
| Timothy C. Barabe | Dir | — | 2 | $301K | 2026-01-02 |
| Emily English | Chief Operations Officer | — | 1 | $30K | 2026-01-02 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Carsten Brunn | President | Sell | $162K | 2026-01-06 |
| Blaine Davis | CFO | Sell | $72K | 2026-01-06 |
| Milos Miljkovic | Chief Medical Officer | Sell | $24K | 2026-01-06 |
| Timothy C. Barabe | Director | Buy | $206K | 2025-12-04 |
| Timothy A. Springer | Director & 10% Owner | Buy | $3.0M | 2025-04-09 |
| Timothy A. Springer | Director & 10% Owner | Buy | $2.7M |
Companies that share insiders with RNAC, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2025-03-18 |
| Timothy A. Springer | Director & 10% Owner | Buy | $660K | 2025-01-13 |
| Emily English | Chief Operations Officer | Sell | $30K | 2025-01-03 |
| Carsten Brunn | CEO & President | Sell | $579K | 2025-01-03 |
| Metin Kurtoglu | CTO | Sell | $82K | 2025-01-03 |
| Milos Miljkovic | Chief Medical Officer | Sell | $32K | 2025-01-03 |
| Christopher M. Jewell | Chief Scientific Officer | Sell | $43K | 2025-01-03 |
| Blaine Davis | CFO | Sell | $268K | 2025-01-03 |
| Timothy A. Springer | Director & 10% Owner | Buy | $1.4M | 2024-12-19 |
| Metin Kurtoglu | CTO | Sell | $690K | 2024-12-09 |